Dual Bronchodilators No Help for Symptomatic Smokers With Preserved Lung Function
Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in former or current smokers with preserved lung function, the RETHINC trial showed. Among 535 symptomatic smokers with a 10 pack-year history and preserved lung function assessed by spirometry, 56.4% in the treatment group and 59.0% in the placebo group had a least a 4-point decrease […]
Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer
Darolutamide (Nubeqa) was linked with a decrease in locally invasive procedures, as well as local urinary and bowel symptoms, in patients with nonmetastatic (nm) castration-resistant prostate cancer (CRPC), according to analysis of the ARAMIS trial. The drug, compared with placebo, was also associated with a delayed deterioration in patient quality of life (QoL) related to […]